Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06594913
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-10
Brief Title:
Eating Disorders Genetics Initiative 2
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Eating Disorders Genetics Initiative 2
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EDGI2
Brief Summary:
The overarching intention of the Eating Disorder Genetics Initiative 2 EDGI2 is to increase sample size diversity and eating disorder phenotypes The investigators are enrolling 20000 new participants with anorexia nervosa AN bulimia nervosa BN binge-eating disorder BED avoidantrestrictive food intake disorder ARFID and controls in the US Mexico Australia New Zealand Sweden and Denmark A primary study goal is to enroll at least 30 of participants from underrepresented groups Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None